Smruthi Organics Limited (BOM:540686)

Market Cap	1.40B +2.0%
Revenue (ttm)	1.02B -19.1%
Net Income	34.26M -3.9%
EPS	2.99 -3.9%
Shares Out	11.45M
PE Ratio	40.87
Forward PE	n/a
Dividend	1.50 (1.23%)
Ex-Dividend Date	Jul 31, 2026

Volume	1,798
Open	122.50
Previous Close	121.85
Day's Range	120.85 - 123.70
52-Week Range	95.00 - 164.00
Beta	-0.03
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About Smruthi Organics

Smruthi Organics Limited manufactures and markets active pharmaceutical ingredient (API) products to India. The company provides API for cardiovascular that includes amlodipine besilate, losartan potassium, telmisartan, s - amlodipine besilate, s - amlodipine malelate, and valsartan; for anti diabetic, which comprises metformin HCL, vildagliptin, teneligliptin, and dapagliflozin; and for anti infectives that consists of ciprofloxacin HCL, diloxanide furoate, norfloxacin, and pefloxacin mesylate, as well as ticagrelor for anti platelets. It also...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1989
• Employees: 267
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540686

Financial Performance

In fiscal year 2026, Smruthi Organics's revenue was 1.02 billion, a decrease of -19.08% compared to the previous year's 1.26 billion. Earnings were 34.26 million, a decrease of -3.85%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 12, 2026

Data Sources Report a data error